Core Insights - Investors are showing a bullish stance on Verizon Communications, with significant options trading activity indicating potential upcoming movements in the stock [1][2] - The overall sentiment among large investors is mixed, with 50% bullish and 25% bearish positions noted in recent trades [3] Options Trading Activity - Benzinga's options scanner identified 12 unusual options trades for Verizon, with a total of $503,860 in call options and $137,341 in put options [2][3] - The targeted price range for Verizon over the last three months is between $32.0 and $50.0, based on volume and open interest in options contracts [4][5] Company Overview - Verizon Communications derives 75% of its total service revenue from wireless services and serves approximately 93 million postpaid and 20 million prepaid customers [10] - The company is the largest wireless carrier in the U.S. and also provides fixed-line telecom services, reaching about 30 million homes and businesses [10] Analyst Ratings and Price Targets - Analysts have set an average target price of $48.25 for Verizon, with individual targets ranging from $44 to $51 from various firms [11][12] - Scotiabank and TD Cowen maintain a Sector Perform and Buy rating respectively, while RBC Capital and JP Morgan hold a Neutral rating [12] Current Market Position - Verizon's stock is currently trading at $41.15, reflecting a slight decrease of -0.1% [14] - The stock's trading volume is reported at 18,208,579, with RSI readings suggesting it may be approaching overbought conditions [14]

Core Insights - Financial giants are showing a bearish sentiment towards AbbVie, with 33% of traders indicating bearish tendencies compared to 11% bullish [1] - Significant investors are targeting a price range for AbbVie between $100.0 and $260.0 over the past three months [2] - AbbVie has a diverse portfolio in immunology and oncology, bolstered by recent acquisitions [8] Trading Activity - Recent options activity for AbbVie includes 9 unusual trades, with 4 puts valued at $326,123 and 5 calls valued at $230,186 [1] - The largest observed options trades include neutral sentiment for puts and bullish sentiment for certain calls, with notable strike prices [7] Analyst Ratings - Analysts have varying target prices for AbbVie, with an average target of $251.0 and individual targets ranging from $220 to $289 [10][11] - JP Morgan maintains an Overweight rating with a target price of $260, while UBS and Citigroup hold Neutral ratings with targets of $220 and $235 respectively [11] Current Performance - AbbVie’s stock price is currently at $229.06, reflecting a decrease of 1.65% with a trading volume of 1,945,474 [13] - The next earnings report for AbbVie is scheduled in 71 days, and current RSI values indicate a neutral position [13]

Core Insights - Deep-pocketed investors are adopting a bearish approach towards Quanta Services, indicating potential significant market movements ahead [1] - The options activity for Quanta Services shows a divided sentiment among investors, with 20% bullish and 30% bearish [2] Options Activity - There have been 10 extraordinary options activities detected for Quanta Services, with a total of 3 puts valued at $101,134 and 7 calls valued at $433,072 [2] - Significant options trades include various call options with strike prices ranging from $350.00 to $460.00, indicating mixed investor sentiment [8] Price Movements - Major market movers are focusing on a price band between $350.0 and $470.0 for Quanta Services over the last three months [3] Volume & Open Interest Trends - An analysis of volume and open interest reveals key insights into liquidity and interest levels for Quanta Services' options, particularly within the strike price range of $350.0 to $470.0 over the past month [4] Company Overview - Quanta Services is a leading provider of specialty contracting services, focusing on infrastructure solutions for electric and gas utilities, communications, pipelines, and energy industries in the U.S., Canada, and Australia [9] Current Position and Expert Ratings - Market experts have issued ratings for Quanta Services, with a consensus target price of $495.0, and various analysts maintaining buy or outperform ratings with target prices ranging from $457 to $526 [10][11] Stock Performance - Quanta Services' stock price is currently at $453.99, reflecting a 1.91% increase with a trading volume of 433,657 [13]

Core Insights - Deep-pocketed investors are showing a bullish sentiment towards Booking Holdings, indicating potential significant developments ahead [1] - The options activity for Booking Holdings is unusually high, with 45% of investors leaning bullish and 12% bearish [2] Options Activity - A total of 31 extraordinary options activities were recorded for Booking Holdings, with 20 puts totaling $2,371,481 and 11 calls amounting to $599,375 [2] - Major market movers are focusing on a price range between $4000.0 and $7300.0 for Booking Holdings over the past three months [3] Volume & Open Interest Trends - Insights into volume and open interest are crucial for understanding liquidity and interest levels in Booking Holdings' options [4] - A snapshot of trends in volume and open interest for calls and puts within the strike price range of $4000.0 to $7300.0 has been provided [4][5] Current Market Position - The average target price for Booking Holdings proposed by five industry analysts is $5966.0 [13] - Analysts from various firms have differing ratings and target prices, with Cantor Fitzgerald maintaining a Neutral rating at $5550, BTIG downgrading to Buy at $6250, Keybanc rating it Overweight at $6630, and Truist Securities maintaining a Buy rating at $5810 [14] Trading Performance - The current trading volume for Booking Holdings stands at 30,036, with the stock price at $4655.77, reflecting a decrease of -0.75% [16] - The stock is currently neutral according to RSI indicators, positioned between overbought and oversold [16]

Financial giants have made a conspicuous bearish move on Micron Technology. Our analysis of options history for Micron Technology (NASDAQ:MU) revealed 50 unusual trades.Delving into the details, we found 34% of traders were bullish, while 48% showed bearish tendencies. Out of all the trades we spotted, 22 were puts, with a value of $2,146,894, and 28 were calls, valued at $2,535,833.Predicted Price RangeTaking into account the Volume and Open Interest on these contracts, it appears that whales have been tar ...

Core Insights - MicroStrategy has experienced a significant decline of over 60% in the past year, contrasting with the S&P 500, which has increased by approximately 12% [2][3] - The company's stock is currently in a downtrend, having broken through a previous support level of 237, with a recent intraday low of 181.73 [3][4] - There are mixed signals in the market, with the RSI indicating a small bullish divergence but also showing oversold conditions, typically a sign of weakness [4][5] Technical Analysis - The stock's price needs to break above the trend line and previous highs near 213-214 for signs of a potential trend reversal [5] - Potential support and resistance levels are identified, with the minus two standard deviation channel aligning with old lows near 214, and the minus three standard deviation channel around 160-130 [6] - Current trading sentiment is bearish, with the stock recently bouncing to about 192, still down 65% from its all-time highs [7][8] Options Strategy - A proposed options strategy involves selling the December 5th weekly options with a 180 strike put and buying a 170 strike put, creating a neutral to bullish put vertical [9][10] - This strategy aims to capitalize on higher implied volatility while providing a cushion of approximately 8% below the current share price, with a break-even point at 177.20 [10] - The probability of the short 180 strike being out of the money at expiration is estimated at about 58%, offering a better chance of success [10]

While all eyes are on Nvidia's (NVDA) earnings report, retailers have been flooding the earnings docket as well. In fact, Dick's Sporting Goods Inc (NYSE:DKS) is headed to the confessional, with third-quarter earnings results due out before the open on Tuesday, Nov. 25. Analysts expect the footwear giant to announce quarterly profits of $2.71 per share on revenue of $4.45 billion.DKS has a mixed post-earnings history, finishing four of its last eight next-day sessions lower and four higher, including a 4.8% ...

Core Viewpoint - Investors are showing a bullish sentiment towards Johnson & Johnson (NYSE: JNJ), indicated by significant options trading activity, suggesting that large investors may anticipate upcoming developments [1][2]. Options Trading Activity - A total of 38 uncommon options trades for Johnson & Johnson were identified, with 26 calls amounting to $2,847,461 and 12 puts totaling $701,701, reflecting a mixed sentiment among traders [2][3]. - The overall sentiment from big-money traders is approximately 50% bullish and 36% bearish, indicating a notable interest in the stock [3]. Price Targets - The targeted price range for Johnson & Johnson's stock over the last three months has been identified between $145.0 and $255.0, based on the volume and open interest of options contracts [4]. Volume and Open Interest - The analysis of volume and open interest provides insights into the liquidity and investor interest in Johnson & Johnson's options, particularly within the strike price range of $145.0 to $255.0 over the past 30 days [5]. Current Market Status - Johnson & Johnson is recognized as the world's largest and most diverse healthcare firm, focusing on innovative medicine and medtech after divesting its consumer business, Kenvue, in 2023 [10]. - The company’s drug division is concentrating on three main therapeutic areas: immunology, oncology, and neurology, with over half of its total revenue generated in the United States [10]. Analyst Ratings - Recent professional analyst ratings indicate an average price target of $190.0 for Johnson & Johnson, with one analyst revising their rating downward to Hold [11][12]. Trading Metrics - The current trading volume for Johnson & Johnson stands at 7,976,739, with the stock price at $202.11, reflecting a 1.06% increase [14].

Deep-pocketed investors have adopted a bullish approach towards Oracle (NYSE:ORCL), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ORCL usually suggests something big is about to happen.We gleaned this information from our observations today when Benzinga's options scanner highlighted 153 extraordinary options activities for Oracle. Thi ...

Core Insights - Investors are showing a bullish stance on Albemarle (NYSE:ALB), indicating potential upcoming developments in the company [1][2] - Recent options trading activity reveals a split sentiment among large investors, with 33% bullish and 33% bearish positions [3] Trading Activity - A total of 27 uncommon options trades for Albemarle were identified, with 11 puts amounting to $565,228 and 16 calls totaling $540,645 [2][3] - Significant investors are targeting a price range for Albemarle between $65.0 and $190.0 over the past three months based on trading activity [4] Options Volume and Open Interest - An analysis of volume and open interest trends for Albemarle's options indicates liquidity and interest in the strike price range of $65.0 to $190.0 over the last 30 days [5][6] Largest Options Trades - Notable options trades include a bullish put trade with a strike price of $190.00 totaling $223.2K and a bearish call trade with a strike price of $75.00 totaling $50.2K [9] Company Overview - Albemarle is a leading lithium producer, primarily serving the battery market, especially for electric vehicles, and operates lithium refining plants globally [11] - The company also produces bromine, which is used in flame retardants [11] Analyst Ratings - Recent analyst ratings for Albemarle show an average target price of $110.8, with various ratings ranging from $91 to $136 from different analysts [13][14] Current Market Status - As of the latest data, Albemarle's stock price is $124.77, reflecting a 2.78% increase, with upcoming earnings expected in 84 days [16]